Venture Life Group (LON:VLG) Insider Purchases £25,166.05 in Stock

Venture Life Group plc (LON:VLG – Get Free Report) insider Daniel Wells purchased 38,717 shares of the business’s stock in a transaction on Wednesday, September 30th. The shares were bought at an average cost of GBX 65 per share, for a total transaction of £25,166.05.

Daniel Wells also recently made the following trade(s):

  • On Thursday, October 1st, Daniel Wells acquired 14,760 shares of Venture Life Group stock. The shares were bought at an average price of GBX 68 per share, with a total value of £10,036.80.

Venture Life Group Stock Performance

Shares of VLG stock opened at GBX 69.41 on Friday. Venture Life Group plc has a 52-week low of GBX 52 and a 52-week high of GBX 72. The company has a quick ratio of 1.48, a current ratio of 4.71 and a debt-to-equity ratio of 0.82. The stock has a market cap of £83.33 million, a PE ratio of 15.88, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23. The business has a 50-day simple moving average of GBX 67.38 and a 200-day simple moving average of GBX 65.11.

Venture Life Group (LON:VLG – Get Free Report) last posted its earnings results on Tuesday, September 29th. The company reported GBX 4.10 EPS for the quarter. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%. On average, equities analysts expect that Venture Life Group plc will post 6.1391542 EPS for the current year.

Venture Life Group Company Profile

(Get Free Report)

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.

See Also

Insider Buying and Selling by Quarter for Venture Life Group (LON:VLG)

Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.